Thirdly, the included studies exhibited variations in the baseline characteristics of the study population (such as sex, BMI, age, and comorbidities) and methodology (including dosage and duration of treatment), which could have impacted adiponectin and insulin resistance levels. The gene discussed is ADIPOQ; the disease is Insulin resistance.